INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 9 filers reported holding INNATE PHARMA S A in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $481,254 | +87.4% | 190,219 | +132.6% | 0.00% | – |
| Q2 2023 | $256,839 | -59.6% | 81,796 | -63.5% | 0.00% | – |
| Q1 2023 | $636,435 | +61.5% | 224,097 | +112.3% | 0.00% | – |
| Q4 2022 | $394,000 | +6.2% | 105,534 | -43.1% | 0.00% | – |
| Q3 2022 | $371,000 | -24.4% | 185,310 | +1.9% | 0.00% | -100.0% |
| Q2 2022 | $491,000 | +274.8% | 181,944 | +366.8% | 0.00% | – |
| Q1 2022 | $131,000 | -87.3% | 38,974 | -79.2% | 0.00% | -100.0% |
| Q4 2021 | $1,031,000 | +53.2% | 187,256 | +71.7% | 0.00% | 0.0% |
| Q3 2021 | $673,000 | +4386.7% | 109,039 | +2326.9% | 0.00% | – |
| Q2 2021 | $15,000 | -88.5% | 4,493 | -85.2% | 0.00% | – |
| Q1 2021 | $131,000 | – | 30,284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 4,545,454 | $29,273,000 | 2.64% |
| Rubric Capital Management LP | 1,350,000 | $8,694,000 | 0.98% |
| Maven Securities LTD | 130,000 | $836,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 44,226 | $284,000 | 0.01% |
| OLD MISSION CAPITAL LLC | 13,038 | $84,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200,000 | $1,288,000 | 0.00% |
| FNY Investment Advisers, LLC | 1,795 | $11,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,353,773 | $8,705,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 74,242 | $477,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |